home / stock / ctic / ctic articles
No one has written and article on CTI BioPharma Corp., stock symbol CTIC. Be the first to contribute and write an article.
News, Short Squeeze, Breakout and More Instantly...
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders PR Newswire SEATTLE , May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization ...
Shares of CTI BioPharma Corp. (NASDAQ: CTIC) traded at a new 52-week high today and are currently trading at $8.99. So far today, approximately 1.79M shares have been exchanged, as compared to an average 30-day volume of 10.16M shares. CTI BioPharma Corp., a biopharmaceutical company, focuses...
NEW YORK, NY / ACCESSWIRE / May 16, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Franchise Group, Inc. (NASDAQ: FRG)'s ...